PharmaBoardroom

Barry Heavey, Head of Life Sciences at IDA Ireland, Ireland’s inward investment promotion agency, discusses IDA’s focus on acting as a catalyst…

Philippe Choukroun (PC) and Patricia Hatesuer (PH) of AAA speak about the Alsace region in France and the attractiveness of the life science cluster…

This map shows the overall contribution of the pharmaceutical industry to the French economy, including number of employees by region, investment…

Singapore, though conscious of its limitations, has been able to leverage its key assets of location, infrastructure and local talent in order to…

With nearly €4 billion of capital investment in large molecule manufacturing underway, Ireland’s strategy to become a premier destination for…

The chairman of BioSingapore, Dr. Siew Hwa Ong, discusses the opportunities and challenges facing biotech SMEs in Singapore, government efforts to…

The below chart shows the sources of funding for R&D investment in Italy, with only 7% of total investment originating from pharmaceutical and…

The following chart gives the key statistics on the Italian pharmaceutical industry; from number of manufacturing plants, to investments and export…

Francisco González, CEO of ProMéxico, the Mexican investment agency, describes the strengths of Mexico’s research and industrial base, untapped…

Philippe Richert, President of the newly created region Grand Est (Regions Alsace, Champagne-Ardenne and Lorraine) shares the significance of life…

After a number of years of difficulty post-2008 and the euro-debt crisis, Ireland’s pharma manufacturing industry and economy in general is now…

The executive director of the French Chamber of Commerce and Industry (FCCI) in Singapore, Carine Lespayandel pinpoints the key facets of the…